Clicky

Ainos, Inc.(AIMD)

Description: Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California.


Keywords: Medicine Clinical Medicine Disease Medical Test Cytokine Point Of Care Testing Interferon Antivirals Treatment Applications

Home Page: ainos.com

AIMD Technical Analysis

8880 Rio San Diego Drive
San Diego, CA 92108
United States
Phone: 858 869 2986


Officers

Name Title
Mr. Chun-Hsien Tsai Chairman of Board, Pres & CEO
Ms. Hui-Lan Wu Chief Financial Officer
Mr. Lawrence Kennedy Lin Exec. VP of Operations
Mr. John Junyong Lee Esq. Chief Legal Counsel, Corp. Counsel & Sec.
Mr. Chih-Heng Lu Corp. Sec. of Board & Director of Corp. Devel.

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.3571
Price-to-Sales TTM: 5.3859
IPO Date: 2013-11-04
Fiscal Year End: December
Full Time Employees: 34
Back to stocks